Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi

Detalhes bibliográficos
Autor(a) principal: Barreto, Aline Silva
Data de Publicação: 2014
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFS
Texto Completo: https://ri.ufs.br/handle/riufs/3259
Resumo: Visceral Leishmaniasis (VL) is a severe desease, endemic in the Brazil, with a tendency to be more prevalent in urban areas. The pathology of VL is associated with a reduced production of IFN-. by T-cells and the increased production of IL-10, which suppresses the activation of macrophages and promotes development of the disease. Activated T cells can express CD40L interacting with CD40 expressed on antigen presenting cells (APC), this interaction is important for the activation of APCs and production of inflammatory cytokines, chemokines, nitric oxide (NO) and metalloproteinases, triggering a protective response in experimental models of LV. Data from our group showed that VL patients have low serum levels of sCD40L before treatment and that these levels increase over the same, titles reaching close to those found in endemic control, suggesting a protective effect of this molecule. In this work we evaluated the participation of sCD40L in modulating the immune response of macrophages infected with Leishmania chagasi. In this work we evaluated the participation of sCD40L in modulating the immune response of macrophages infected with Leishmania chagasi. For this, human macrophages were infected with promastigotes of Leishmania chagasi in the presence of serum containing high titers of sCD40L with and without addition of blocking antibody, anti-CD40L. After 72 hours, the microbicidal response was evaluated by number of infected macrophages and the number of intracellular parasites We observed that there was a 43% reduction in the percentage of infected macrophages and 58% of the number of intracellular parasites when compared to the medium (P = 0.01) and this effect was reversed by the blockade of sCD40L, because there was a 24% increase in the percentage of infected macrophages and 33% of the number of amastigotes. From the results we can conclude that the sCD40Lestá related to development of a protective immune response by activating microbicidal mechanisms of macrophages to control infection by L. chagasi.
id UFS-2_222bd80f95341baa45d19e4361279a84
oai_identifier_str oai:ufs.br:riufs/3259
network_acronym_str UFS-2
network_name_str Repositório Institucional da UFS
repository_id_str
spelling Barreto, Aline Silvahttp://lattes.cnpq.br/5511870618431215Moura, Tatiana Rodrigues dehttp://lattes.cnpq.br/02383256316031632017-09-25T13:59:21Z2017-09-25T13:59:21Z2014-05-10https://ri.ufs.br/handle/riufs/3259Visceral Leishmaniasis (VL) is a severe desease, endemic in the Brazil, with a tendency to be more prevalent in urban areas. The pathology of VL is associated with a reduced production of IFN-. by T-cells and the increased production of IL-10, which suppresses the activation of macrophages and promotes development of the disease. Activated T cells can express CD40L interacting with CD40 expressed on antigen presenting cells (APC), this interaction is important for the activation of APCs and production of inflammatory cytokines, chemokines, nitric oxide (NO) and metalloproteinases, triggering a protective response in experimental models of LV. Data from our group showed that VL patients have low serum levels of sCD40L before treatment and that these levels increase over the same, titles reaching close to those found in endemic control, suggesting a protective effect of this molecule. In this work we evaluated the participation of sCD40L in modulating the immune response of macrophages infected with Leishmania chagasi. In this work we evaluated the participation of sCD40L in modulating the immune response of macrophages infected with Leishmania chagasi. For this, human macrophages were infected with promastigotes of Leishmania chagasi in the presence of serum containing high titers of sCD40L with and without addition of blocking antibody, anti-CD40L. After 72 hours, the microbicidal response was evaluated by number of infected macrophages and the number of intracellular parasites We observed that there was a 43% reduction in the percentage of infected macrophages and 58% of the number of intracellular parasites when compared to the medium (P = 0.01) and this effect was reversed by the blockade of sCD40L, because there was a 24% increase in the percentage of infected macrophages and 33% of the number of amastigotes. From the results we can conclude that the sCD40Lestá related to development of a protective immune response by activating microbicidal mechanisms of macrophages to control infection by L. chagasi.A Leishmaniose Visceral (LV) é uma doença grave e endêmica no Brasil, sendo mais prevalente em áreas urbanas. A patologia da LV está associada a uma menor produção de IFN-. por células T e ao aumento da produção de IL-10, que suprime a ativação dos macrófagos e promove o desenvolvimento da doença. Células T ativadas podem expressar CD40L que interagem com o CD40 expresso em células apresentadoras de antígeno (APC), essa interação é importante para a ativação de APCs e produção de citocinas inflamatórias, quimiocinas, óxido nítrico (NO) e metaloproteinases, desencadeando uma resposta protetora em modelos experimentais de LV. Dados do nosso grupo demostraram que pacientes com LV apresentam baixos níveis séricos de sCD40L antes do tratamento e que esses níveis aumentam no decorrer do mesmo, atingindo títulos próximos aos valores encontrados no controle endêmico, sugerindo um efeito protetor dessa molécula. Neste trabalho avaliamos a participação do sCD40L presente no soro na resposta microbicida de macrófagos infectados por Leishmania chagasi. Para isso, macrófagos humanos obtidos a partir de PBMC foram infectados com promastigotas de Leishmania chagasi na presença de soro contendo altos títulos de sCD40L, com e sem adição de anticorpo de bloqueio, anti-CD40L. Avaliamos a resposta microbicida a partir do número de macrófagos infectados e a quantidade de parasitos intracelulares. Observamos que houve uma redução de 43% do percentual de macrófagos infectados e de 58% do número de parasitos intracelulares quando comparado ao meio (p=0.01), sendo esse efeito foi revertido com o bloqueio do sCD40L, pois ocorreu um aumento de 24% do percentual de macrófagos infectados e de 33% do número de amastigotas. A partir dos resultados obtidos concluimos que o sCD40L está relacionado ao desenvolvimento de uma resposta imunológica protetora por ativar mecanismos microbicidas dos macrófagos para o controle da infecção por L. chagasi.application/pdfporLeishmaniose visceralMacrófagosAntígenosImunologiaEpidemiologiaLigante de CD40EpidemiologyImmunologyKala-azarMacrophagesCD40 ligandCNPQ::CIENCIAS BIOLOGICAS::MICROBIOLOGIA::BIOLOGIA E FISIOLOGIA DOS MICROORGANISMOSParticipação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasiinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisPós-Graduação em Biologia Parasitáriainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSORIGINALALINE_SILVA_BARRETO.pdfapplication/pdf919344https://ri.ufs.br/jspui/bitstream/riufs/3259/1/ALINE_SILVA_BARRETO.pdf04a836f63e3aef589a1387cafd5e56a4MD51TEXTALINE_SILVA_BARRETO.pdf.txtALINE_SILVA_BARRETO.pdf.txtExtracted texttext/plain77527https://ri.ufs.br/jspui/bitstream/riufs/3259/2/ALINE_SILVA_BARRETO.pdf.txtb234ff7034b0bd914a779335e02087c5MD52THUMBNAILALINE_SILVA_BARRETO.pdf.jpgALINE_SILVA_BARRETO.pdf.jpgGenerated Thumbnailimage/jpeg1271https://ri.ufs.br/jspui/bitstream/riufs/3259/3/ALINE_SILVA_BARRETO.pdf.jpg2df83df509f12c54584bcf92ce65cd8aMD53riufs/32592017-11-24 21:27:42.392oai:ufs.br:riufs/3259Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2017-11-25T00:27:42Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false
dc.title.por.fl_str_mv Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
title Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
spellingShingle Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
Barreto, Aline Silva
Leishmaniose visceral
Macrófagos
Antígenos
Imunologia
Epidemiologia
Ligante de CD40
Epidemiology
Immunology
Kala-azar
Macrophages
CD40 ligand
CNPQ::CIENCIAS BIOLOGICAS::MICROBIOLOGIA::BIOLOGIA E FISIOLOGIA DOS MICROORGANISMOS
title_short Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
title_full Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
title_fullStr Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
title_full_unstemmed Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
title_sort Participação do CD40-L Solúvel (sCD40-L) na resposta microbicida de macrófagos infectados por Leishmania chagasi
author Barreto, Aline Silva
author_facet Barreto, Aline Silva
author_role author
dc.contributor.author.fl_str_mv Barreto, Aline Silva
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/5511870618431215
dc.contributor.advisor1.fl_str_mv Moura, Tatiana Rodrigues de
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/0238325631603163
contributor_str_mv Moura, Tatiana Rodrigues de
dc.subject.por.fl_str_mv Leishmaniose visceral
Macrófagos
Antígenos
Imunologia
Epidemiologia
Ligante de CD40
topic Leishmaniose visceral
Macrófagos
Antígenos
Imunologia
Epidemiologia
Ligante de CD40
Epidemiology
Immunology
Kala-azar
Macrophages
CD40 ligand
CNPQ::CIENCIAS BIOLOGICAS::MICROBIOLOGIA::BIOLOGIA E FISIOLOGIA DOS MICROORGANISMOS
dc.subject.eng.fl_str_mv Epidemiology
Immunology
Kala-azar
Macrophages
CD40 ligand
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::MICROBIOLOGIA::BIOLOGIA E FISIOLOGIA DOS MICROORGANISMOS
description Visceral Leishmaniasis (VL) is a severe desease, endemic in the Brazil, with a tendency to be more prevalent in urban areas. The pathology of VL is associated with a reduced production of IFN-. by T-cells and the increased production of IL-10, which suppresses the activation of macrophages and promotes development of the disease. Activated T cells can express CD40L interacting with CD40 expressed on antigen presenting cells (APC), this interaction is important for the activation of APCs and production of inflammatory cytokines, chemokines, nitric oxide (NO) and metalloproteinases, triggering a protective response in experimental models of LV. Data from our group showed that VL patients have low serum levels of sCD40L before treatment and that these levels increase over the same, titles reaching close to those found in endemic control, suggesting a protective effect of this molecule. In this work we evaluated the participation of sCD40L in modulating the immune response of macrophages infected with Leishmania chagasi. In this work we evaluated the participation of sCD40L in modulating the immune response of macrophages infected with Leishmania chagasi. For this, human macrophages were infected with promastigotes of Leishmania chagasi in the presence of serum containing high titers of sCD40L with and without addition of blocking antibody, anti-CD40L. After 72 hours, the microbicidal response was evaluated by number of infected macrophages and the number of intracellular parasites We observed that there was a 43% reduction in the percentage of infected macrophages and 58% of the number of intracellular parasites when compared to the medium (P = 0.01) and this effect was reversed by the blockade of sCD40L, because there was a 24% increase in the percentage of infected macrophages and 33% of the number of amastigotes. From the results we can conclude that the sCD40Lestá related to development of a protective immune response by activating microbicidal mechanisms of macrophages to control infection by L. chagasi.
publishDate 2014
dc.date.issued.fl_str_mv 2014-05-10
dc.date.accessioned.fl_str_mv 2017-09-25T13:59:21Z
dc.date.available.fl_str_mv 2017-09-25T13:59:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://ri.ufs.br/handle/riufs/3259
url https://ri.ufs.br/handle/riufs/3259
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.program.fl_str_mv Pós-Graduação em Biologia Parasitária
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFS
instname:Universidade Federal de Sergipe (UFS)
instacron:UFS
instname_str Universidade Federal de Sergipe (UFS)
instacron_str UFS
institution UFS
reponame_str Repositório Institucional da UFS
collection Repositório Institucional da UFS
bitstream.url.fl_str_mv https://ri.ufs.br/jspui/bitstream/riufs/3259/1/ALINE_SILVA_BARRETO.pdf
https://ri.ufs.br/jspui/bitstream/riufs/3259/2/ALINE_SILVA_BARRETO.pdf.txt
https://ri.ufs.br/jspui/bitstream/riufs/3259/3/ALINE_SILVA_BARRETO.pdf.jpg
bitstream.checksum.fl_str_mv 04a836f63e3aef589a1387cafd5e56a4
b234ff7034b0bd914a779335e02087c5
2df83df509f12c54584bcf92ce65cd8a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)
repository.mail.fl_str_mv repositorio@academico.ufs.br
_version_ 1802110803235569664